[nilesh]

Discuss about dcth nda here. Welcome to Courses.ind.in and this page is for dcth nda discussion. If you are looking for information on dcth nda then ask your question is as much details as possible in the “Reply” box provided below. The more detailed your question will be, the more easy will it be for our experts to answers your query. And if you have any updated or latest information on dcth nda, then please share you knowledge with our experts in the “Reply” box below. Your reply will be published here and your knowledge can help many people. Thanks for stopping by at Courses.ind.in. Please visit again.

Would you please tell me details of Delcath Systems, Inc if FDA accepted New Drug Application of company so that I can go through it?

[Vishal Kotkar]

According to me yea FDA has accepted the Delcath Systems, Inc New Drug Application and here I will get details of company.

The Delcath Systems, Inc is a publicly-traded specialty pharmaceutical and medical device company helps to develops percutaneous perfusion technologies of high-dose chemotherapeutic agents to specific organs or regions of the body.

Ongoing Clinical Trials
Phase 3 FOCUS Trial in Hepatic Dominant Ocular Melanoma

Phase 2 Clinical Trials in Hepatocellular Carcinoma (HCC) and Intrahepatic Cholangiocarcinoma (ICC)

Board of Director
Roger G. Stoll, PH.D.
Executive Chairman

Harold S. Koplewicz, M.D.
Director

William D. Rueckert
Director

Jennifer Simpson, PhD., M.S.N., C.R.N.P.
Director

Dr. Marco Taglietti
Director

Management
Jennifer Simpson, PhD., M.S.N., C.R.N.P.
President and Chief Executive Officer

John Purpura
Executive Vice President Regulatory Affairs, Quality Assurance

Barbra C. Keck
Senior Vice President, Finance

Address:-
Delcath Systems, Inc
1633 Broadway
22nd Floor, Suite C
New York, NY 10019

Phone:-
(212) 489-2100